Prof. David Nutt

U.K.'s Prof. David Nutt Ranked World's Top Psychopharmacologist: More On His Contributions & Advocacy

British Prof. David Nutt Talks About Need For Psychedelic-Assisted Therapy During Australia Visit

Clearmind Gears Up For Clinical Trial To Test Drug That Treats Alcohol Addiction

British Prof. David Nutt Talks About Need For Psychedelic-Assisted Therapy During Australia Visit

Clearmind Gears Up For Clinical Trial To Test Drug That Treats Alcohol Addiction

Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: The Legal Situation

A Foundational Study On Stroke Is Ready. Here Is Why It's Important

Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: The Legal Situation

A Foundational Study On Stroke Is Ready. Here Is Why It's Important

Australia: An Initial $700K In Funding For Observational Trials Of Psychedelic-Assisted Therapies

UK: Psychiatrists Send Letter To Royal College Of Psychiatrists To Reschedule Psilocybin

Prof. David Nutt Recent News

Meet PAREA, The European Partnership For Novel Psychedelic-Assisted Therapies Access & Research Is Launching This June

The research renaissance into the neuroscience and therapeutic applications of psychedelics represents one of the most promising initiatives in brain science and neuropsychopharmacology, given the huge unmet needs in the therapeutic areas they aim to treat.

Psyched: German Government Funds Psilocybin Study, Field Trip Opens Psilocybin Clinic

Global Developments in Germany, Canada and Brazil Germany has approved a large phase 2b study on psilocybin for treatment-resistant depression.